The role of salvage extended lymph node dissection in patients with rising PSA and PET/CT scan detected nodal recurrence of prostate cancer
D Porres, D Pfister, A Thissen, TH Kuru… - Prostate Cancer and …, 2017 - nature.com
BACKGROUND: Non-prostatic bed recurrence of prostate cancer (PCa) is usually treated
with androgen deprivation therapy (ADT). We analyzed the impact of salvage extended …
with androgen deprivation therapy (ADT). We analyzed the impact of salvage extended …
The role of salvage extended lymph node dissection in patients with rising PSA and PET/CT scan detected nodal recurrence of prostate cancer
D Porres, D Pfister, A Thissen… - Prostate cancer …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Non-prostatic bed recurrence of prostate cancer (PCa) is usually treated with
androgen deprivation therapy (ADT). We analyzed the impact of salvage extended lymph …
androgen deprivation therapy (ADT). We analyzed the impact of salvage extended lymph …
The role of salvage extended lymph node dissection in patients with rising PSA and PET/CT scan detected nodal recurrence of prostate cancer.
D Porres, D Pfister, A Thissen, TH Kuru… - Prostate Cancer and …, 2017 - go.gale.com
BACKGROUND: Non-prostatic bed recurrence of prostate cancer (PCa) is usually treated
with androgen deprivation therapy (ADT). We analyzed the impact of salvage extended …
with androgen deprivation therapy (ADT). We analyzed the impact of salvage extended …
The role of salvage extended lymph node dissection in patients with rising PSA and PET/CT scan detected nodal recurrence of prostate cancer.
D Porres, D Pfister, A Thissen, TH Kuru… - Prostate Cancer and …, 2016 - europepmc.org
Background Non-prostatic bed recurrence of prostate cancer (PCa) is usually treated with
androgen deprivation therapy (ADT). We analyzed the impact of salvage extended lymph …
androgen deprivation therapy (ADT). We analyzed the impact of salvage extended lymph …
The role of salvage extended lymph node dissection in patients with rising PSA and PET/CT scan detected nodal recurrence of prostate cancer
D Porres, D Pfister, A Thissen, TH Kuru… - Prostate Cancer …, 2017 - kups.ub.uni-koeln.de
BACKGROUND: Non-prostatic bed recurrence of prostate cancer (PCa) is usually treated
with androgen deprivation therapy (ADT). We analyzed the impact of salvage extended …
with androgen deprivation therapy (ADT). We analyzed the impact of salvage extended …
The role of salvage extended lymph node dissection in patients with rising PSA and PET/CT scan detected nodal recurrence of prostate cancer
D Porres, D Pfister, A Thissen, TH Kuru… - Prostate Cancer and …, 2017 - hero.epa.gov
BACKGROUND: Non-prostatic bed recurrence of prostate cancer (PCa) is usually treated
with androgen deprivation therapy (ADT). We analyzed the impact of salvage extended …
with androgen deprivation therapy (ADT). We analyzed the impact of salvage extended …
The role of salvage extended lymph node dissection in patients with rising PSA and PET/CT scan detected nodal recurrence of prostate cancer
D Porres, D Pfister, A Thissen, TH Kuru… - Prostate Cancer …, 2017 - kups.ub.uni-koeln.de
BACKGROUND: Non-prostatic bed recurrence of prostate cancer (PCa) is usually treated
with androgen deprivation therapy (ADT). We analyzed the impact of salvage extended …
with androgen deprivation therapy (ADT). We analyzed the impact of salvage extended …
The role of salvage extended lymph node dissection in patients with rising PSA and PET/CT scan detected nodal recurrence of prostate cancer
D Porres, D Pfister, A Thissen, TH Kuru… - Prostate Cancer and …, 2017 - go.gale.com
BACKGROUND: Non-prostatic bed recurrence of prostate cancer (PCa) is usually treated
with androgen deprivation therapy (ADT). We analyzed the impact of salvage extended …
with androgen deprivation therapy (ADT). We analyzed the impact of salvage extended …